1	Suppression	suppression	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	TNFalpha-mediated	tnfalpha-mediated	_	_	_	_	_	_	_
4	NFkappaB	NFkappaB	_	_	_	_	_	_	_
5	activity	activity	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	myricetin	myricetin	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	other	other	_	_	_	_	_	_	_
10	flavonoids	flavonoid	_	_	_	_	_	_	_
11	through	through	_	_	_	_	_	_	_
12	downregulating	downregulate	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	IKK	IKK	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	ECV304	ecv304	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Flavonoids	flavonoid	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	group	group	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	naturally-occurring	naturally-occurring	_	_	_	_	_	_	_
7	phenolic	phenolic	_	_	_	_	_	_	_
8	compounds	compound	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	plant	plant	_	_	_	_	_	_	_
12	kingdom	kingdom	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	many	many	_	_	_	_	_	_	_
16	flavonoids	flavonoid	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	found	find	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	vascular	vascular	_	_	_	_	_	_	_
21	protective	protective	_	_	_	_	_	_	_
22	properties	property	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Nevertheless	nevertheless	_	_	_	_	_	_	_
2	how	how	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	protective	protective	_	_	_	_	_	_	_
5	response	response	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	exerted	exert	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	flavonoids	flavonoid	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	well	well	_	_	_	_	_	_	_
13	characterized	characterize	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	view	view	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	nuclear	nuclear	_	_	_	_	_	_	_
6	factor-kappaB	factor-kappab	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	NFkappaB	NFkappaB	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	may	may	_	_	_	_	_	_	_
11	play	play	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	central	central	_	_	_	_	_	_	_
14	role	role	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	initiation	initiation	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	atherosclerosis	atherosclerosis	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	prevention	prevention	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	activation	activation	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	NFkappaB	NFkappaB	_	_	_	_	_	_	_
27	represents	represent	_	_	_	_	_	_	_
28	an	an	_	_	_	_	_	_	_
29	important	important	_	_	_	_	_	_	_
30	role	role	_	_	_	_	_	_	_
31	in	in	_	_	_	_	_	_	_
32	protecting	protect	_	_	_	_	_	_	_
33	vascular	vascular	_	_	_	_	_	_	_
34	injury	injury	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	effects	effect	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	flavonoids	flavonoid	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	NFkappaB/inhibitor-kappaB	NFkappaB/inhibitor-kappaB	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	IkappaB	IkappaB	_	_	_	_	_	_	_
13	)	)	_	_	_	_	_	_	_
14	system	system	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	ECV304	ecv304	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	activated	activate	_	_	_	_	_	_	_
19	with	with	_	_	_	_	_	_	_
20	tumor	tumor	_	_	_	_	_	_	_
21	necrosis	necrosis	_	_	_	_	_	_	_
22	factor-alpha	factor-alpha	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	TNFalpha	TNFalpha	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	were	be	_	_	_	_	_	_	_
27	examined	examine	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	investigated	investigate	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	inhibitory	inhibitory	_	_	_	_	_	_	_
5	action	action	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	six	six	_	_	_	_	_	_	_
8	flavonoids	flavonoid	_	_	_	_	_	_	_
9	on	on	_	_	_	_	_	_	_
10	IkappaB	IkappaB	_	_	_	_	_	_	_
11	kinase	kinase	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	IKK	IKK	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	activity	activity	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	an	an	_	_	_	_	_	_	_
18	enzyme	enzyme	_	_	_	_	_	_	_
19	recently	recently	_	_	_	_	_	_	_
20	found	find	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	phosphorylate	phosphorylate	_	_	_	_	_	_	_
23	critical	critical	_	_	_	_	_	_	_
24	serine	serine	_	_	_	_	_	_	_
25	residues	residue	_	_	_	_	_	_	_
26	of	of	_	_	_	_	_	_	_
27	IkappaB	IkappaB	_	_	_	_	_	_	_
28	for	for	_	_	_	_	_	_	_
29	degradation	degradation	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Of	of	_	_	_	_	_	_	_
2	six	six	_	_	_	_	_	_	_
3	flavonoids	flavonoid	_	_	_	_	_	_	_
4	tested	test	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	myricetin	myricetin	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	found	find	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	strongly	strongly	_	_	_	_	_	_	_
11	inhibit	inhibit	_	_	_	_	_	_	_
12	IKK	IKK	_	_	_	_	_	_	_
13	kinase	kinase	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	prevent	prevent	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	degradation	degradation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	IkappaBalpha	IkappaBalpha	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	IkappaBbeta	IkappaBbeta	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	activated	activate	_	_	_	_	_	_	_
26	endothelial	endothelial	_	_	_	_	_	_	_
27	cells	cell	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	myricetin	myricetin	_	_	_	_	_	_	_
4	was	be	_	_	_	_	_	_	_
5	also	also	_	_	_	_	_	_	_
6	found	find	_	_	_	_	_	_	_
7	to	to	_	_	_	_	_	_	_
8	inhibit	inhibit	_	_	_	_	_	_	_
9	NFkappaB	NFkappaB	_	_	_	_	_	_	_
10	activity	activity	_	_	_	_	_	_	_
11	correlated	correlate	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	suppression	suppression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	monocyte	monocyte	_	_	_	_	_	_	_
16	adhesion	adhesion	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	ECV304	ecv304	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Therefore	therefore	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	conclude	conclude	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	flavonoids	flavonoid	_	_	_	_	_	_	_
6	may	may	_	_	_	_	_	_	_
7	be	be	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	therapeutic	therapeutic	_	_	_	_	_	_	_
10	value	value	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	vascular	vascular	_	_	_	_	_	_	_
13	disease	disease	_	_	_	_	_	_	_
14	through	through	_	_	_	_	_	_	_
15	down	down	_	_	_	_	_	_	_
16	regulation	regulation	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NFkappaB/IkappaB	NFkappaB/IkappaB	_	_	_	_	_	_	_
19	system	system	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	Copyright	Copyright	_	_	_	_	_	_	_
2	1999	1999	_	_	_	_	_	_	_
3	Wiley-Liss	Wiley-Liss	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	Inc	Inc	_	_	_	_	_	_	_
6	.	.	_	_	_	_	_	_	_

